Dania Annuar
Papers
1
Total Citations
3
H-Index
1
About
Dr. Dania Annuar is a pioneering researcher in the field of hepatobiliary oncology, with a focused expertise in personalized medicine for intrahepatic cholangiocarcinoma (ICC). Her major contribution lies in the development and application of patient-derived organoids for drug screening, a breakthrough that addresses the urgent need for novel therapeutic strategies in ICC—a cancer where median survival remains under one year despite standard treatments. Her most-cited work, published in 2020, demonstrates how these organoids can be used to tailor drug selection for individual patients, offering a path beyond the limited targetable mutations in ICC. With 3 citations, this foundational study has laid the groundwork for a new paradigm in precision oncology. Dr. Annuar’s research is notable for bridging the gap between laboratory models and clinical application, directly tackling the challenge of gemcitabine and cisplatin resistance. Her work is a beacon for students and researchers interested in translational cancer research, organoid technology, and the fight against one of the most aggressive liver cancers.
Research Focus
Key Achievements
Top Papers
- 1